Pfizer has reported preliminary results of a late-stage study found its experimental torcetrapib "good" cholesterol drug, when combined with its Lipitor drug, raised blood pressure more than was found in previous studies.
The results show the an average increase in systolic blood pressure of about 1 millimeter of mercury above the 2-to-3 millimeter range seen in earlier studies, the company said.
Hmmm!
Source: Reuters
1 comment:
Post a Comment